Dighton, MA, United States of America

Debra Lafreniere



 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2010-2016

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Debra Lafreniere: Innovator in Nucleic Acid Delivery Systems

Introduction

Debra Lafreniere is a prominent inventor based in Dighton, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of nucleic acid delivery systems. With a total of five patents to her name, her work focuses on innovative methods for administering nucleic acids to treat various autoimmune diseases.

Latest Patents

One of Lafreniere's latest patents is titled "Nucleic acid microspheres, production and delivery thereof." This invention involves preparing nucleic acids by dissolving compounds in a suitable solvent and forming microspheres from the resulting solution. These microspheres are designed to be administered to individuals as a protective measure in conditions where nucleic acid delivery is beneficial, such as in the treatment of autoimmune diseases.

Another notable patent is "Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes." In this patent, AS-oligonucleotides are delivered in microsphere form to induce dendritic cell tolerance, particularly in the non-obese-diabetic (NOD) mouse model. The microspheres incorporate antisense oligonucleotides, and the process aims to prevent autoimmune diabetes conditions in NOD mice both in vivo and in situ.

Career Highlights

Throughout her career, Debra Lafreniere has worked with notable companies such as Baxter International Inc. and Baxter Healthcare. Her experience in these organizations has contributed to her expertise in the field of biotechnology and patent development.

Collaborations

Lafreniere has collaborated with several professionals in her field, including Larry Richard Brown and Vered Bisker-Leib. These collaborations have likely enhanced her research and development efforts in nucleic acid delivery systems.

Conclusion

Debra Lafreniere is a distinguished inventor whose work in nucleic acid delivery systems has the potential to transform treatments for autoimmune diseases. Her innovative patents and collaborations reflect her commitment to advancing biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…